Adcock Ingram Holdings (JSE:AIP) Total Current Assets : R4,691 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Adcock Ingram Holdings's total current assets for the quarter that ended in Dec. 2023 was R4,691 Mil.

Adcock Ingram Holdings Total Current Assets Historical Data

The historical data trend for Adcock Ingram Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings Total Current Assets Chart

Adcock Ingram Holdings Annual Data

Trend

Sep13

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Current Assets

Get a 7-Day Free Trial

3,558.62

3,864.42

3,737.71

4,344.99

4,614.42

Adcock Ingram Holdings Semi-Annual Data
	Mar14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Current Assets	Get a 7-Day Free Trial															4,103.26	4,344.99	4,486.58	4,614.42	4,690.93

Adcock Ingram Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Adcock Ingram Holdings's Total Current Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	91.54	+	1948.881	+	2449.611	+	124.385
	=	4,614

Adcock Ingram Holdings's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	107.141	+	2179.249	+	2404.537	+	0
	=	4,691

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Adcock Ingram Holdings (JSE:AIP) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Adcock Ingram Holdings's Liquidation Value for the quarter that ended in Dec. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	107.141	-	2853.155	+	0.75 * 2179.249	+	0.5 * 2404.537
=	91

Adcock Ingram Holdings Total Current Assets Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Adcock Ingram Holdings (JSE:AIP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682

Website

https://www.adcock.com

Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.